CD19 and viral infectious disease: At day 4 PI we observed that B cells (CD19+) from TLR3KO mice responded to viral infection by upregulating surface expression of the activation marker CD69 and the costimulatory molecule CD86 to levels comparable to that observed on B cells from WT NOD mice (Figure S3).